Airsculpt Technologies Inc Revenue per Employee (AIRS), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket
 


Airsculpt Technologies Inc   (NASDAQ: AIRS)
    Sector • Healthcare    Industry • Healthcare Facilities
   Industry • Healthcare Facilities
   Sector • Healthcare
 

Airsculpt Technologies Inc 's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


Airsculpt Technologies Inc 's Revenue per employee fell on a trailing twelve month basis to $ 415,218, below the company average number of $434,069.
Within the Healthcare sector Employees of 222 other companies have achieved higher revenue per employee. While Airsculpt Technologies Inc 's total ranking has deteriorated compared to the previous quarter from 1531 to 1858. Airsculpt Technologies Inc has 363 employees.


What is Sales per Employee Ratio?







AIRS Revenue per Employee (Jun 30 2026)
II. Quarter
(Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
(Jun 30 2025)
II. Quarter
Y / Y Revenue Change -2.53 % 0.05 % -14.64 % -17.76 % -13.71 %
Sales per Employee (TTM) $ 415,218 418,281 418,231 434,033 454,846
AIRS's Total Ranking # 1858 # 1531 # 1733 # 211 # 61
Seq. Revenue Change 8.91 % 17.78 % -4.43 % -20.49 % 11.79 %


Revenue per Employee Company Ranking
Within: No.
Healthcare Facilities Industry # 11
Healthcare Sector # 223
Overall Market # 1858

Revenue per Employee Statistics
High Average Low
$ 544,694 $ 434,069 $ 95,457
(Mar 31 2024)   (Sep 30 2021)



Financial Statements
Airsculpt Technologies Inc 's Revenue MRQ $ 43 Millions Visit AIRS's Income Statement
Airsculpt Technologies Inc 's Revenues TTM $ 151 Millions Visit AIRS's aggregate revenue growth
What are AIRS's Sales? Visit AIRS's Sales by Segment


  News about Airsculpt Technologies Inc Revenue per employee

AirSculpt Technologies Faces Uncertain Future Amid Leadership Changes and Declining Employee Productivity,

By Miami Beach, Fla. — AirSculpt Technologies, Inc. (NASDAQ: AIRS) is implementing strategic changes and updating projections for fiscal year 2024, yet the company s recent performance metrics signal a tougher road ahead. With the company gearing up to present at the ICR Conference 2025, questions linger about its capacity to regain traction in an increasingly competitive landscape.On January 13, 2025, AirSculpt issued a press release updating guidance for fiscal 2024. This announcement coincided with Yogi Jashnani’s recent appointment as CEO, effective January 7, 2025, succeeding Dennis Dean, who will transition back to his role as Chief Financial Officer. This significant leadership shift is positioned as a revitalization strategy, aimed at elevating the company s operational efficacy and market competitiveness.

AirSculpt Technologies Elevates Leadership with Yogi Jashnani as New CEO, Poised for Strategic Growth

In a significant move that underscores its commitment to innovation and excellence in the field of body contouring, AirSculpt Technologies, Inc. (NASDAQ:AIRS) has announced the appointment of Yogi Jashnani as the new Chief Executive Officer (CEO) and a member of the Board of Directors. This strategic leadership transition is set to take effect on January 7, 2025, with Yogi succeeding Dennis Dean, who has served as Interim CEO and will continue in his role as Chief Financial Officer.Miami Beach-based AirSculpt is recognized as a pioneering entity in the body contouring industry, specializing in premium procedures that cater to an increasingly discerning clientele. Under the leadership of Jashnani, the company is expected to harness his industry expertise and visionary outlook to drive further growth and enhance its competitive edge.




Other Ratios
Airsculpt Technologies Inc 's Income per Employee
Employees in Healthcare Facilities
Healthcare Facilities Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
AIRS's Revenue per Employee versus Healthcare Facilities Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for AIRS's Competitors
Revenue per Employee for AIRS's Suppliers
Revenue per Employee for AIRS's Customers

You may also want to know
AIRS's Sales Growth Rates AIRS's Pe Price to earnings ratio AIRS's Receivables Turnover Ratio AIRS's Stock Quote
AIRS's Net Income Growth Rates AIRS's Ps Price to Sales ratio AIRS's Sales per Employee AIRS's Asset Turnover Ratio
AIRS's Net Margin AIRS's Pb Price to Book ratio AIRS's Financial Strength Ratios AIRS's Dividend Payout Ratio
Date modified: 2026-09-26T07:41:04+00:00




Companies with similar Revenue per Employee for 12 months ending Jun 30 2026, within Healthcare Sector Revenue per Employee Revenue 12 months ending Jun 30 2026Number of Employees Jun 30 2026
Veracyte Inc   721,503.31 $ 544.735  Million 755 
Xtant Medical Holdings Inc   720,185.43 $ 108.748  Million 151 
Harrow Inc   719,172.77 $ 274.724  Million 382 
Ars Pharmaceuticals Inc   717,343.56 $ 116.927  Million 163 
Sunshine Biopharma Inc   706,935.44 $ 35.347  Million 50 
Johnson and Johnson  695,518.47 $ 97,929.000  Million 140,800 
Inspire Medical Systems inc   674,588.90 $ 899.227  Million 1,333 
Mannkind Corporation  664,915.54 $ 393.630  Million 592 
Intuitive Surgical Inc   663,668.41 $ 11,296.300  Million 17,021 
Biolife Solutions Inc   662,696.77 $ 102.718  Million 155 
Zoetis Inc   656,344.83 $ 9,517.000  Million 14,500 
Urogen Pharma Ltd   647,137.46 $ 188.317  Million 291 
Insmed Inc  646,978.37 $ 1,076.572  Million 1,664 
Phathom Pharmaceuticals Inc   645,991.91 $ 239.663  Million 371 
Premier Air Charter Holdings Inc   644,120.78 $ 31.562  Million 49 
Karyopharm Therapeutics Inc   643,074.56 $ 146.621  Million 228 
Evofem Biosciences Inc   622,241.38 $ 18.045  Million 29 
Nexgel Inc   621,578.95 $ 11.810  Million 19 
Bioventus Inc   618,197.87 $ 581.106  Million 940 
Koru Medical Systems Inc   617,911.44 $ 45.108  Million 73 
Organon and Co   613,900.00 $ 6,139.000  Million 10,000 
Nature s Sunshine Products inc   610,161.29 $ 491.790  Million 806 
Delcath Systems Inc   602,935.90 $ 94.058  Million 156 
Nephros Inc   602,388.89 $ 21.686  Million 36 
Caredx Inc   598,809.15 $ 458.089  Million 765 
Jaguar Health Inc   591,808.51 $ 27.815  Million 47 
Milestone Scientific Inc   590,317.47 $ 8.855  Million 15 
Waters Corporation  587,879.62 $ 4,644.249  Million 7,900 
Phibro Animal Health Corporation  582,288.29 $ 1,516.861  Million 2,605 
Rhythm Pharmaceuticals Inc   579,512.08 $ 239.918  Million 414 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.